Cancer treatment

Cancer treatment encompasses a wide array of therapeutic strategies aimed at controlling or eliminating cancerous cells within the body. These strategies include chemotherapy, radiation therapy, immunotherapy, targeted therapy, and surgical interventions. Each treatment modality targets different aspects of cancer cell biology, such as cell division, DNA replication, or immune evasion. Research in cancer treatment focuses on improving the efficacy, specificity, and safety of these therapies to enhance patient outcomes and reduce side effects. At CymitQuimica, we provide a comprehensive range of compounds and reagents to support your research in developing innovative and effective cancer treatments.

20
- 50
- 100
- 200

products per page. 959 products on this category.

Product data	Purity	Price range	Estimated delivery
Fulvestrant Enantiomer REF: 4Z-F-3139	- - -	To inquire	Tue 10 Dec 24
Nintedanib Impurity 34 REF: 4Z-N-066051CAS: 2036139-30-5	- - -	To inquire	Tue 10 Dec 24
Nintedanib Impurity 20 REF: 4Z-N-066034CAS: 1912-28-3	- - -	To inquire	Tue 10 Dec 24
Palbociclib REF: TM-T1785CAS: 571190-30-2	98% - 99.9%	52.00 €~96.00 €	Tue 10 Dec 24
N1, N2-Di-Nitroso Palbociclib REF: 4Z-P-196083	- - -	To inquire	Tue 10 Dec 24
Palbociclib Impurity 60 REF: 4Z-P-196067CAS: 2488840-59-9	- - -	To inquire	Tue 10 Dec 24
Olaparib Impurity 36 REF: 4Z-O-032041	- - -	To inquire	Tue 10 Dec 24
Enzalutamide Impurity 32 REF: 4Z-E-068045CAS: 393-06-6	- - -	To inquire	Tue 10 Dec 24
Goserelin EP Impurity C REF: 4Z-PG-1510	- - -	To inquire	Tue 10 Dec 24
Abiraterone Impurity 17 REF: 4Z-A-8255CAS: 154229-21-7	- - -	To inquire	Tue 10 Dec 24
Carfilzomib Impurity 28 REF: 4Z-C-121031CAS: 143415-51-4	- - -	To inquire	Tue 10 Dec 24
Gimeracil Impurity 2 REF: 4Z-G-047002	- - -	To inquire	Tue 10 Dec 24
Nintedanib Impurity 27 REF: 4Z-N-066043	- - -	To inquire	Tue 10 Dec 24
Olaparib Impurity 4 REF: 4Z-O-032006CAS: 1021298-68-9	- - -	To inquire	Tue 10 Dec 24
Lenvatinib-d5 REF: 4Z-L-124056	- - -	To inquire	Tue 10 Dec 24
Carfilzomib Impurity 29 REF: 4Z-C-121032	- - -	To inquire	Tue 10 Dec 24
Enzalutamide Impurity 25 REF: 4Z-E-068038CAS: 609783-45-1	- - -	To inquire	Tue 10 Dec 24
Enzalutamide Impurity 41 REF: 4Z-E-068054CAS: 869936-86-7	- - -	To inquire	Tue 10 Dec 24
Tamoxifen N-oxide REF: 4Z-T-0111CAS: 75504-34-6	- - -	To inquire	Tue 10 Dec 24
Nintedanib Impurity 59 REF: 4Z-N-066077	- - -	To inquire	Tue 10 Dec 24

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

10mg		To inquire
25mg		To inquire
50mg		To inquire
100mg		To inquire

5mg		52.00 €
10mg		73.00 €

Cancer treatment

Fulvestrant Enantiomer

Ref: 4Z-F-3139

Nintedanib Impurity 34

Ref: 4Z-N-066051

Nintedanib Impurity 20

Ref: 4Z-N-066034

Palbociclib

Ref: TM-T1785

N1, N2-Di-Nitroso Palbociclib

Ref: 4Z-P-196083

Palbociclib Impurity 60

Ref: 4Z-P-196067

Olaparib Impurity 36

Ref: 4Z-O-032041

Enzalutamide Impurity 32

Ref: 4Z-E-068045

Goserelin EP Impurity C

Ref: 4Z-PG-1510

Abiraterone Impurity 17

Ref: 4Z-A-8255

Carfilzomib Impurity 28

Ref: 4Z-C-121031

Gimeracil Impurity 2

Ref: 4Z-G-047002

Nintedanib Impurity 27

Ref: 4Z-N-066043

Olaparib Impurity 4

Ref: 4Z-O-032006

Lenvatinib-d5

Ref: 4Z-L-124056

Carfilzomib Impurity 29

Ref: 4Z-C-121032

Enzalutamide Impurity 25

Ref: 4Z-E-068038

Enzalutamide Impurity 41

Ref: 4Z-E-068054

Tamoxifen N-oxide

Ref: 4Z-T-0111

Nintedanib Impurity 59

Ref: 4Z-N-066077